0
Animals
Experimental drug doubles one-year survival in pancreatic cancer
April 18, 2026
Scroll
Posted 3 hours ago by
A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.
Live Science
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: center
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.